SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001785530-21-000013
Filing Date
2021-05-28
Accepted
2021-05-28 08:07:29
Documents
1
Period of Report
2021-05-27

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_162220363642407.html 4  
1 FORM 4 wf-form4_162220363642407.xml 4 4021
  Complete submission text file 0001785530-21-000013.txt   5408
Mailing Address 3000 KENT AVE STE A1-100 WEST LAFAYETTE IN 47906
Business Address
Sherman Michael A. (Reporting) CIK: 0001509463 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40366 | Film No.: 21976219

Mailing Address 1030 MASSACHUSETTS AVENUE SUITE 210 CAMBRIDGE MA 02138
Business Address 1030 MASSACHUSETTS AVENUE SUITE 210 CAMBRIDGE MA 02138 617-952-0555
Werewolf Therapeutics, Inc. (Issuer) CIK: 0001785530 (see all company filings)

IRS No.: 823523180 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations